AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
ZWS

Zurn Elkay Water Solutions Corporation Common Stock (ZWS) fair value

Industrials · Pollution & Treatment Controls · NYSE · United States
$48.55-0.23%
Market cap $8.1BNext earnings 2026-10-27Updated Oct 20, 2026
Add earnings to calendarGoogle
Our verdict
Trades 119% above our fair value
Price
$48.55
Model fair valueConfidence: good
$22.21
Model range
$15.87 to $32.06
Fair value $22.21
Price $48.55
4 models fit Zurn Elkay Water Solutions Corporation Common Stock and they disagree: 1 of 4 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)
Valued as a cyclical company: P/E comparison, EV/EBITDA comparison, Discounted cash flow, and Graham number.
ACCE opinionZurn Elkay Water Solutions Corporation Common Stock (ZWS)
Fair value (4 models)
$22.21
ACCE price target
$44.00
Rating
Overvalued
Horizon
12 months
Fair value published on 16 Oct 2026, 00:00 CEST; previously $22.91 since 11 Oct 2026, 00:00 CEST.
ACCE price target published on 10 Oct 2026, 00:00 CEST.
Rating published on 20 Oct 2026, 15:04 CEST.
Price used: $48.55 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, EV/EBITDA comparison, Graham number, and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
118.6% above
-54.2% to fair value
ACCE score
65
out of 100
Analysts
40% buy
10 covering
P/E
30.2x
forward 23.9x
1-year return
+5.9%
Dividend yield
1.07%

Zurn Elkay Water Solutions Corporation Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Zurn Elkay Water Solutions makes commercial plumbing and water-management products: drinking fountains and bottle fillers, faucets and flush valves, backflow prevention devices, and water filtration systems sold largely into non-residential construction and building retrofit. The case rests on its installed base and specification-driven demand, since its products are written into building codes and architect specs, which supports pricing and repeat replacement business. Revenue growth of 10.5% and a 49.0% gross margin with a 31.4% operating margin point to a business that is converting volume into unusually high profitability. At a 29.1x trailing and 22.9x forward P/E, the market is already pricing in continued execution, so the question for a deeper look is whether margins hold as non-residential construction activity cycles. The 16.9% ROE and absence from major indices suggest it is a smaller, less-followed name that could reward closer work on its order backlog and end-market mix.

AI-assisted·How I use AIWritten Oct 18, 2026

AI research notes

AI-assisted·How I use AIWritten Oct 16, 2026 · figures from 2026-10-15 · prices to Oct 23, 2026
Why it could do well
  • Free cash flow over the last twelve months reached $317M, giving the business real cash to fund growth and buybacks.
  • Analysts' mean price target of $57.56 sits 22.9% above the current share price, and 4 of 10 rate the stock Buy or Strong Buy.
  • The latest quarter beat expectations, with earnings per share of 0.50 against 0.47 expected, a 6.4% surprise.
Why it could disappoint
  • The consensus fair value of $22.40 is 52.2% below the $46.83 share price, a large gap for the stock to justify.
  • At a trailing P/E of 29.2x and forward P/E of 22.9x, the stock trades above the sector median forward P/E of 23.8x on a higher multiple.
  • Return on invested capital of 7.4% is modest, and the 4.0% free cash flow yield offers a thin cushion at this price.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Oct 27, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where ZWS's valuation models land
Price
$48.55
Model fair value
$22.21
Model range
$15.87 to $32.06
Fair value $22.21
Price $48.55
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Mixed40% buy · 10 covering analysts
● Strong buy 3● Buy 1● Hold 6● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+3.2%
1 month
+3.8%
3 months
+0.4%
6 months
-7.5%
YTD
+4.4%
1 year
+5.9%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
20 Oct 2026, 15:04 CESTRatingOvervaluedfirst publication$47.12
16 Oct 2026, 00:00 CESTFair value$22.40$22.91$47.09
11 Oct 2026, 00:00 CESTFair value$22.91$26.50$46.57
10 Oct 2026, 00:00 CESTACCE price target$44.00first publication$46.24
28 Sept 2026, 00:00 CESTFair value$26.50$26.82$46.65
25 Sept 2026, 00:00 CESTFair value$26.82$26.44$46.78
16 Sept 2026, 00:00 CESTFair value$26.44$26.84$46.09
3 Sept 2026, 00:00 CESTFair value$26.84$27.42$46.64
25 Aug 2026, 00:00 CESTFair value$27.42$27.77$48.75
20 Aug 2026, 00:00 CESTFair value$27.77$31.69$49.38

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full ZWS page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth76Value50Quality79Momentum56Total65
Valuation
Trailing P/E
30.2x
Forward P/E
23.9x
PEG
0.23
P/B
4.68x
EV / Revenue
4.4x
Book value/sh
$9.99
Enterprise value
$7.9B
Profitability
ROE
16.9%
FCF yield
3.95%
ROIC
7.4%
Health and risk
Debt / equity
0.36
Dividend yield
1.07%
Beta
0.83

Price

+4.7% · 1Y

Ask anything about ZWS

Answered from Zurn Elkay Water Solutions Corporation Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 20% of peers
low 11.8x30.2xhigh 45.2x
ROEbetter than 67% of peers
low -2%17%high 34%
Div yieldbetter than 33% of peers
low 0.0%1.1%high 5.7%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
ZWS Zurn Elkay Water Solutions Corporation Common Stock$48.55$22119% above30.2x16.9%7965
6370.T Kurita Water Industries Ltd.¥7055.00--16.9x13.5%6164
6368.T Organo Corporation¥2309.00--19.4x21.6%8055
CECO CECO Environmental Corp. Common Stock$51.51$4515% above--2.4%4441
VLTO Veralto Corp Common Stock $104.90$6465% above25.5x34.3%8466
MTRS.ST Munters Group AB (publ)kr 126.35kr 9041% above45.2x9.9%4649
7004.T Kanadevia Corporation¥1046.00--11.8x7.8%4356

Sector report card

Where ZWS ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Oct 14, 2026
    Zurn Elkay Water Solutions Schedules Third Quarter 2026 Earnings Release and Investor Conference Call
  • Business Wire•Sep 2, 2026
    Zurn Elkay Water Solutions Named One of America’s Greatest Companies 2026 by Newsweek
  • Business Wire•Aug 3, 2026
    Zurn Elkay Water Solutions Named One of America’s Best Companies 2026 by TIME
5 more press releases · full archive on Investor+.INVESTOR
40 filings
October 2026
Oct 16
Form 4Insider transactionPeriod 2026-10-15
View on SEC →
Oct 16
Form 4Insider transactionPeriod 2026-10-15
View on SEC →
Oct 16
Form 4Insider transactionPeriod 2026-10-15
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR